? Core A The overall goals of the Mayo Clinic SPORE in Ovarian Cancer are to stimulate innovative research in ovarian cancer and to expedite the translation of discoveries into new and better methods of prevention, detection and treatment of this disease. The Administrative Core has facilitated progress toward these goals by serving as the organizational hub of the Mayo Ovarian SPORE during Years 1-5 of funding. During the next funding period (Years 6-10), it will continue to provide organizational and communications support for the SPORE leadership, research projects, scientific cores and developmental programs [Developmental Research Program (DRP) and Career Development Program (CDP)]. Specifically, the Administrative Core will: 1) provide leadership and organizational support to SPORE investigators; 2) oversee formal procedures for scientific review of SPORE research projects; 3) oversee and facilitate the efforts of all cores; 4) manage and coordinate SPORE fiscal activities; 5) monitor accrual, including minority accrual, to all SPORE clinical trials, population research studies and biospecimen collections; 6) provide guidance and administrative support to the DRP and CDP leadership; 7) facilitate the activities of the Executive Committee and implement its decisions; 8) facilitate engagement of the SPORE advocates; 9) facilitate reviews of the SPORE by the EAB and ISAC; 10) organize monthly SPORE seminars, scientific meetings and the annual retreat; 11) assure ongoing integration of the Ovarian SPORE with the Mayo Clinic Cancer Center and its Women's Cancer Program; 12) serve as the administrative liaison between the Mayo Ovarian SPORE, the NCI SPORE Program, other Mayo SPOREs, and external collaborators; 13) identify and catalyze research collaborations in ovarian cancer, including collaborations with the other Ovarian SPOREs; 14) communicate SPORE-related research developments and opportunities to Mayo investigators; and 15) assist the SPORE Director in preparing reports of Ovarian SPORE activities, including annual progress reports and the competitive renewal application.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA136393-06A1
Application #
8932127
Study Section
Special Emphasis Panel (ZCA1-RPRB-C (M1))
Project Start
2008-10-01
Project End
2020-08-31
Budget Start
2015-09-11
Budget End
2016-08-31
Support Year
6
Fiscal Year
2015
Total Cost
$587,017
Indirect Cost
$513,937
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Botuyan, Maria Victoria; Cui, Gaofeng; Drané, Pascal et al. (2018) Mechanism of 53BP1 activity regulation by RNA-binding TIRR and a designer protein. Nat Struct Mol Biol 25:591-600
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Earp, Madalene; Tyrer, Jonathan P; Winham, Stacey J et al. (2018) Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One 13:e0197561
O'Mara, Tracy A; Glubb, Dylan M; Amant, Frederic et al. (2018) Identification of nine new susceptibility loci for endometrial cancer. Nat Commun 9:3166
Wu, Chenming; Luo, Kuntian; Zhao, Fei et al. (2018) USP20 positively regulates tumorigenesis and chemoresistance through ?-catenin stabilization. Cell Death Differ 25:1855-1869
Msaouel, Pavlos; Opyrchal, Mateusz; Dispenzieri, Angela et al. (2018) Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects. Curr Cancer Drug Targets 18:177-187
Li, Lei; Liu, Tongzheng; Li, Yunhui et al. (2018) The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization. Oncogene 37:2422-2431
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Wu, Dongyan; Yang, Haitao; Winham, Stacey J et al. (2018) Mediation analysis of alcohol consumption, DNA methylation, and epithelial ovarian cancer. J Hum Genet 63:339-348
Painter, Jodie N; O'Mara, Tracy A; Morris, Andrew P et al. (2018) Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Med 7:1978-1987

Showing the most recent 10 out of 294 publications